“This is very important because it's randomized, so if there's a signal we'll know that it's due to the hydroxychloroquine,” he says.

The team has found a ready candidate — an anti-malaria drug called hydroxychloroquine.

The prescription drug hydroxychloroquine is sometimes used to decrease inflammation in patients with lupus erythematosus and rheumatoid arthritis.